Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€102.64

€102.64

0.260%
0.26
0.260%
€135.74
 
19.07.24 / Tradegate WKN: A0D9T1 / Symbol: DXCM / Name: DexCom / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Dexcom Inc. Stock

The Dexcom Inc. stock is trending slightly upwards today, with an increase of €0.26 (0.260%) compared to yesterday's price.
With 18 Buy predictions and not the single Sell prediction the community is currently very high on Dexcom Inc..
As a result the target price of 135 € shows a positive potential of 31.53% compared to the current price of 102.64 € for Dexcom Inc..
For the coming years our community has positive and negative things to say abot the Dexcom Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.

Pros and Cons of Dexcom Inc. in the next few years

Pros
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Dexcom Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Dexcom Inc. 0.260% -1.874% -5.887% -12.558% -8.324% 8.413% 202.862%
Zimmer Holdings -1.220% 1.856% 0.594% -20.788% -7.682% -20.196% -6.818%
Dentsply Sirona Inc. 0.600% 3.545% 1.849% -33.843% -24.674% -55.144% -51.971%
Teleflex Inc. -1.490% -1.485% 5.291% -13.478% -10.360% -38.957% -32.906%

Comments

Prediction Buy
Perf. (%) -1.31%
Target price 121.123
Change
Ends at 12.07.25

DexCom, Inc. (NASDAQ: DXCM) had its price target lowered by analysts at Stifel Nicolaus from $145.00 to $132.00. They now have a "buy" rating on the stock.
Ratings data for DXCM provided by MarketBeat
Show more

DexCom, Inc. (NASDAQ: DXCM) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for DXCM provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -12.88%
Target price 149.552
Change
Ends at 26.04.25

DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Raymond James from $151.00 to $160.00. They now have a "strong-buy" rating on the stock.
Ratings data for DXCM provided by MarketBeat
Show more

News

Top 4 Must-Have Healthcare Stocks for Long-Term Growth: https://www.marketbeat.com/logos/articles/med_20240711100558_top-4-must-have-healthcare-stocks-for-long-term-gr.jpg
Top 4 Must-Have Healthcare Stocks for Long-Term Growth

The healthcare industry represents a substantial and dynamic market sector, presenting many opportunities for investors seeking long-term growth and stability. Factors such as the aging

Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.


DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will hold a conference call

Dexcom Expands AID Partnership Into The Netherlands: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Expands AID Partnership Into The Netherlands


DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced that people living with Type 1 diabetes in the Netherlands will be